JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
StreetZero Signal 69
About JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
Jazz Pharmaceuticals Public Limited Company is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Founded in 2003 and headquartered in Dublin, Ireland, the company operates as a public entity listed on NASDAQ under the ticker JAZZ. It develops novel biopharmaceutical medicines for unmet medical needs.
LATEST FUNDINGRule 144
$16.2M
Announced 2026-11-06
TOTAL RAISED$265M
IN THE NEWS
- 🔗 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
- 🔗 Jazz Pharmaceuticals - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 Jazz Pharmaceuticals Denmark ApS - 2026 Company Profile - Tracxn
- 🔗 Jazz Pharmaceuticals, Inc. Announces Initial Public Offering | Jazz Pharmaceuticals plc
- 🔗 Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) Stock Price, Quote, News & History | Nasdaq
EMPLOYEES—
FOUNDED2003
HQDublin, Ireland
Industry
Public Equity (NASDAQ)
Tags
PharmaceuticalsBiotechPublicNeurology
Investors
Key highlights
- Completed $16.2M Rule 144 placement as public company.
- Went public via IPO on NASDAQ in 2007 at $18 per share.
- Focuses on neurology and psychiatry therapeutics.
- Has raised over $265M in pre-IPO funding from multiple VC firms.
Ask StreetZero about JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account